200-059-4

Applied Filters:

Keyword:'200-059-4'

Showing 1-1 of 1 result for "200-059-4" within Papers

Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small-cell lung cancer: OLCSG 0007.

Yoshihiko Segawa et al.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 28(20), 3299-3306 (2010-06-10)

To demonstrate the efficacy of docetaxel and cisplatin (DP) chemotherapy with concurrent thoracic radiotherapy (TRT) for patients with locally advanced non-small-cell lung cancer (LA-NSCLC). Patients age 75 years or younger with LA-NSCLC, stratified by performance status, stage, and institution, were

Page 1 of 1